I am a little confused.  In an earlier post, you wrote:

"I don’t think we need hope Dr Ray puts a “spin” on positive secondary endpoints. As a former clinical researcher myself, I’m know that the effects cognitive function and kidney function will be very important to him. If they have positive outcomes, he will give them plenty of publicity!"

But in today's post, you are saying that Dr Ray will focus on CVD only.  Can you please explain? 

Thanks

Iconoclast